MEGAN DAUGHERTY: Open Payments
NPI 1871184036 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,503 in 61 payments from 9 companies in 2025. Trend: 2023 $845 · 2024 $1,037 · 2025 $1,503
Food & beverage: $1,503
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $412 |
| Gilead Sciences, Inc. | 13 | $287 |
| ABBVIE INC. | 13 | $237 |
| Ardelyx, Inc. | 5 | $185 |
| Aimmune Therapeutics, Inc. | 9 | $151 |
| Celltrion USA Inc. | 5 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| EVOKE PHARMA, INC. | 2 | $32 |
| GENZYME CORPORATION | 1 | $16 |
Products named: TREMFYA, IBSRELA, RINVOQ, ZENPEP, VEGZELMA, Epclusa, SKYRIZI, ENTYVIO.
Industry payments across VA — which companies pay providers there.
